Nestlé’s innovation: elevating infant nutrition with HMOs and probiotic synergy for science-based early-life health

Nestlé, a global leader in nutrition and wellness, is taking a giant leap forward in early-life nutrition with its latest innovation – Sinergity.

Nestlé, a global leader in nutrition and wellness, is taking a giant leap forward in early-life nutrition with its latest innovation – Sinergity. This proprietary blend combines a specific probiotic with six human milk oligosaccharides (HMOs) to support age-adapted infant development by unlocking specific health benefits. Nestlé’s dedication to pioneering research and development has led to the creation of this groundbreaking solution, offering essential nutrients for infants who cannot be exclusively breastfed. Sinergity aims to promote age-appropriate growth, digestive health, bone and muscle development, cognitive growth, and a robust immune system in infants.

The Role of Probiotics and HMOs in Infant Health

Probiotics and HMOs play pivotal roles in supporting infant health. Probiotics are essential for nurturing the gut microbiome and strengthening immunity during early life, while HMOs, found in breastmilk, are crucial for fostering intestinal microbiota development and nurturing the immune system.

Nestlé has been at the forefront of researching the composition of breastmilk and understanding the significance of nutrients and bioactives like HMOs. The company has also accumulated extensive expertise in probiotics and their influence on nutrition and health.

Unlocking Synergistic Benefits

Nestlé’s experts have delved into the interaction between these different nutrients and bioactives. They have discovered that a specific strain, B. infantis LMG11588, can efficiently absorb and metabolize HMOs, producing key beneficial compounds in addition to the direct benefits offered by the HMOs and probiotics individually. This combination creates a synergistic effect, leading to a prevalence of bifidobacteria in the gut. These bifidobacteria, through their metabolic activity, create a more favorable gut environment and strengthen the infant’s immunity.

Laurent Alsteens, Global Head of Early Childhood Nutrition at Nestlé, expressed the company’s commitment to groundbreaking research and its collaboration with healthcare professionals to provide optimal nutrition for babies who cannot be exclusively breastfed. Sinergity is a testament to this commitment, offering ingredient blends that support age-appropriate growth, digestive health, bone and muscle development, cognitive growth, and the immune system.

The Development of Sinergity

Nestlé’s teams leveraged their profound expertise to create Sinergity, a proprietary blend containing an infant-specific probiotic strain along with a blend of six HMOs. Research has shown that the composition of HMOs in breastmilk changes during the lactation period. To meet the specific needs of infants as they grow, products containing Sinergity feature varying levels of six different HMOs.

Isabelle Bureau-Franz, Head of Nestlé’s R&D for Nutrition, highlighted Nestlé’s pioneering role in early-life science-based solutions. Through continuous scientific advancements, the company discovered the significant benefits of combining their proprietary B. infantis probiotic with a blend of six HMOs. This breakthrough solution was developed by successfully translating new scientific findings, scaling up probiotic production, and carefully adjusting HMO levels based on age.

Global Rollout and Commitment to Early-Life Nutrition

Sinergity has been launched in Hong Kong, marking the beginning of a global rollout. Latin America is set to receive the product towards the end of this year, followed by Europe early next year, under the NAN Supreme pro brand.

This launch underscores Nestlé’s unwavering commitment to developing science-based solutions for early-life nutrition. Nestlé was the first company to introduce infant formula containing a complex of 5 HMOs globally, and it currently offers products containing HMOs in more than 50 countries.

In conclusion, Nestlé’s Sinergity is a testament to the company’s dedication to advancing early-life nutrition through groundbreaking research and innovative solutions. By combining probiotics and HMOs in a synergistic blend, Nestlé is set to enhance the health and well-being of infants worldwide, offering a bright and healthy start to their lives.